Mounjaro Pens: Demystifying Lifespan and How Long 4 Pens Last

Last reviewed: July 13, 2026

Last updated: July 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide therapy follows a structured 16-week dose escalation protocol where patients begin at 2.5 mg and gradually increase to therapeutic levels. Understanding how long your medication supply lasts helps you plan ahead and avoid gaps in treatment continuity.

How Tirzepatide Dose Escalation Works

Tirzepatide treatment starts with a 2.5 mg weekly injection and increases by 2.5 mg every four weeks until reaching your target dose, typically 10 mg or 15 mg. This gradual escalation allows your body to adapt and minimizes gastrointestinal side effects that can occur with rapid dose increases. Each pen contains 1 mg of tirzepatide, meaning a single 2.5 mg dose requires 2.5 injections from one pen.

The standard escalation schedule spans 16 weeks: weeks 1-4 at 2.5 mg, weeks 5-8 at 5 mg, weeks 9-12 at 7.5 mg, and weeks 13-16 at 10 mg. Some patients advance to 12.5 mg or 15 mg for maximum therapeutic benefit, though this requires an additional 4-8 weeks. This structured approach ensures your body reaches optimal insulin sensitivity and glucose control gradually.

Calculating Your Four-Pen Supply Duration

Four tirzepatide pens contain a total of 4 mg of medication across all four pens. During the 16-week escalation phase, you'll consume approximately 3.25 mg total across four weekly injections (2.5 mg × 4 weeks plus 5 mg × 4 weeks plus 7.5 mg × 4 weeks plus 10 mg × 4 weeks divided by the total weeks). This means four pens provide enough supply to cover your entire escalation phase and potentially one additional week at maintenance dose.

Once you reach your target maintenance dose—typically 10 mg weekly—each pen lasts approximately 7-10 days depending on your prescribed amount. Four pens at maintenance dosing last roughly 4-5 weeks, making your monthly refill pattern consistent and predictable. PlexusDx ensures you receive your next month's supply before current pens deplete, eliminating treatment gaps.

Monthly Supply Patterns for Tirzepatide Therapy

PlexusDx delivers tirzepatide injections on a monthly subscription at $289/mo month-to-month, or from $249/mo on the 6-month plan, with your dose potentially increasing while your price remains flat. During escalation months, your single monthly supply covers the complete dose progression schedule without additional charges. Once you stabilize at your maintenance dose—whether 10 mg, 12.5 mg, or 15 mg weekly—your monthly pens adjust to match that consistent dosing.

The flat monthly pricing structure means upgrading from a 10 mg to 15 mg maintenance dose doesn't increase your cost, removing financial barriers to optimization. Most patients receive four to five pens per month depending on escalation stage, with clear dosing instructions for each weekly injection. PlexusDx tracks your escalation timeline and automatically adjusts shipments to align with your protocol progression.

Optimizing Your Tirzepatide Supply with Genetic Insights

Individual responses to tirzepatide vary based on genetic factors affecting your GLP-1 receptor signaling, glucose metabolism, and appetite regulation pathways. PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways including the GLP1R rs6923761 variant, which influences your medication response speed and optimal dosing timeline. Patients with specific genetic profiles may reach therapeutic benefit faster or require different dose escalation patterns than standard protocols.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will four tirzepatide pens last the entire month?

Four tirzepatide pens typically last 4-5 weeks at maintenance dosing of 10 mg weekly, though the exact duration depends on your current escalation stage. During the 16-week escalation phase, four pens cover the entire progression. PlexusDx coordinates monthly refills to arrive before your supply depletes, ensuring continuous treatment without gaps.

How many injections does one tirzepatide pen provide?

Each tirzepatide pen contains 1 mg of medication. A single 2.5 mg dose requires 2.5 injections from one pen, meaning one pen yields approximately 10 individual 0.1 mg injections or four 2.5 mg weekly doses spread across weeks. At 10 mg maintenance dosing, one pen provides approximately one week of therapy.

Does my price increase if my tirzepatide dose goes up?

No. PlexusDx tirzepatide injections maintain flat monthly pricing at $289/mo month-to-month, or from $249/mo on the 6-month plan regardless of dose escalation or maintenance level adjustments. Your dose may increase from 2.5 mg to 15 mg over time, but your monthly cost remains unchanged, eliminating price barriers to optimal treatment.

What happens if I need to pause or extend my tirzepatide escalation?

Some patients experience side effects requiring dose delays or extended time at lower escalation steps. PlexusDx providers can adjust your escalation timeline while maintaining your monthly subscription, meaning your four-pen supply may stretch longer if you hold at a lower dose for additional weeks. Your flat monthly pricing continues regardless of escalation pacing.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, and GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Do Genetics Affect How Long My Reproductive Years Will Last
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.